New and Media

Media Release
March 18, 2021
Nationwide Children’s Hospital Affiliate Andelyn Biosciences Receives Significant Investment and Enters Into Strategic Partnership with Pall Corporation and Cytiva
Blog
October 22, 2021
Andelyn Biosciences is building the best cell and gene therapy team in spite of a talent shortage and competitive talent...
News
September 30, 2021
Andelyn Biosciences Inc. is adding a second laboratory in Dublin, and will move into its headquarters in Ohio State University's Innovation District before construction is complete.
Blog
September 23, 2021
The analytical requirements for viral vectors used to deliver gene therapies are complex and constantly evolving. The keys to success,...
Blog
September 16, 2021
The number of gene therapy candidates in development is growing rapidly, with many advancing toward late-stage trials. The majority of...
Media Release
August 25, 2021
TetraScience, the R&D Data Cloud company, announced today that Andelyn Biosciences, Inc. has selected the Tetra Data Platform (TDP) to build a cloud-native development and manufacturing service for its customers.
Blog
August 23, 2021
Abstract: Andelyn Biosciences, a full-spectrum gene therapy CDMO organization that supports clients from preclinical studies through phase III trials, originally...
Blog
June 20, 2021
Adeno-associated viruses (AAV) are small viruses that can infect humans and other primate species. The particularity about AAV is that...
Media Release
March 18, 2021
COLUMBUS, Ohio – Andelyn Biosciences, Inc, a contract development and manufacturing organization (CDMO) and an affiliate company of Nationwide Children’s Hospital, has...
Blog
February 15, 2021
“What’s in a name?” the saying goes. In this case, much more than meets the eye. Andelyn Biosciences is much...
Media Release
November 25, 2020
COLUMBUS, Ohio – Andelyn Biosciences, an affiliate company of Nationwide Children’s Hospital that manufactures gene therapy products for the biotechnology and pharmaceutical...